Catalyst Wire Dossier Catalyst Wire Dossier

Mersarex

iclaprim · Arpida A/S
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Mersarex, covering 2009-10-23 to 2009-10-23. Get the full timeline:

Most recent: Arpida A/S withdraws its marketing authorisation application for Mersarex (iclaprim)

See pricing